Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
1.170
+0.020 (1.74%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Company Description

Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States.

The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain.

It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis.

Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

Tenon Medical, Inc.
Tenon Medical logo
Country United States
Founded 2012
IPO Date Apr 27, 2022
Industry Medical Devices
Sector Healthcare
Employees 27
CEO Steven Foster

Contact Details

Address:
104 Cooper Court
Los Gatos, California 95032
United States
Phone 408-649-5760
Website tenonmed.com

Stock Details

Ticker Symbol TNON
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $5.00
CIK Code 0001560293
CUSIP Number 88066N303
ISIN Number US88066N3035
Employer ID 45-5574718
SIC Code 3841

Key Executives

Name Position
Steven M. Foster Chief Executive Officer, President and Director
Richard Ginn Founder, Chief Technology Officer and Director
Kevin Williamson Chief Financial Officer
Richard M. Ferrari Founder and Executive Chairman
Steve Moscaret Senior Vice President of Sales and Marketing

Latest SEC Filings

Date Type Title
Apr 16, 2025 424B3 Prospectus
Apr 15, 2025 EFFECT Notice of Effectiveness
Apr 8, 2025 D Notice of Exempt Offering of Securities
Apr 8, 2025 D Notice of Exempt Offering of Securities
Apr 8, 2025 D Notice of Exempt Offering of Securities
Apr 4, 2025 S-1 General form for registration of securities under the Securities Act of 1933
Mar 28, 2025 8-K Current Report
Mar 27, 2025 8-K Current Report
Mar 27, 2025 424B5 Filing
Mar 26, 2025 10-K Annual Report